Baylor College of Medicine has announced the addition of two new members to its Board of Trustees in a recent press release. The new trustees, Judge Lee H. Rosenthal and Henry J.N. “Kitch” Taub II, have been invited to join the board of the health sciences facility, which aims to improve knowledge on science as well as education, healthcare, and community service both locally and globally.
Rosenthal has served as a judge of the United States District Court in the Southern District of Texas Houston Division since 1992, as well as a member of the American Law Institute. At the institute, Rosenthal worked as an advisor at the Employment Law project, the Aggregate Litigation project, and the Transnational Rules of Civil Procedure project. She also was invited to serve in several designated courts of appeals throughout the United States.
In addition, the judge is already a trustee of the Board of Trustees of Rice University, chair of the Academic Affairs Committee, and a member of the Duke University School of Law Board of Visitors.
Rosenthal along with Taub, the vice president of Abercrombie & Kitch, Inc., will join the Board of Trustees of the Baylor College of Medicine under the direction of the chair James T. Hackett, who was appointed to the position last June.
In addition to his current corporate position, Taub serves as chairman of the Harris County Hospital District Foundation’s Board, as well as trustee of the Baylor Medical Foundation. For more than 20 years he has been a member of the Taub Foundation, which he now presides. Taub has also been nominated director of the Texas Ranger Association Foundation and president of the Pauline Sterne Wolff Memorial Foundation. Prior to that, Taub’s experience includes leading several foundations and charitable trusts, such as the Houston Youth Symphony and Ballet, the Institute of Rehabilitation and Research and St. John’s School.
Baylor recently launched a new study in collaboration with the Alliance for Clinical Trials in Oncology and the National Cancer Institute (NCI), entitled “The Men’s Eating and Living (MEAL) Study: A Randomized Trial of Diet to Alter Disease” (MEAL), which is currently looking for men diagnosed with prostate cancer to participate. The study aims to evaluate the benefits of a diet with high amounts of fruits and vegetables on cancer progression, and quality of life, and is one of the several research projects in which the facility’s scientists are working on.